Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 19
1982 14
1983 33
1984 77
1985 198
1986 130
1987 134
1988 121
1989 155
1990 129
1991 114
1992 88
1993 61
1994 60
1995 57
1996 81
1997 64
1998 72
1999 56
2000 66
2001 66
2002 55
2003 68
2004 65
2005 83
2006 70
2007 70
2008 78
2009 68
2010 79
2011 86
2012 96
2013 102
2014 115
2015 139
2016 115
2017 117
2018 130
2019 127
2020 178
2021 200
2022 199
2023 228
2024 263
2025 111

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,364 results

Results by year

Filters applied: . Clear all
Page 1
Aztreonam.
Johnson DH, Cunha BA. Johnson DH, et al. Med Clin North Am. 1995 Jul;79(4):733-43. doi: 10.1016/s0025-7125(16)30036-0. Med Clin North Am. 1995. PMID: 7791420 Free article. Review.
Aztreonam is a monocyclic beta-lactam antibiotic that is active exclusively against the aerobic gram-negative bacilli. ...Overuse of aztreonam should be avoided to prevent the emergence of resistant P. aeruginosa strains. ...
Aztreonam is a monocyclic beta-lactam antibiotic that is active exclusively against the aerobic gram-negative bacilli. ...Overuse of …
Aztreonam.
Tunkel AR, Scheld WM. Tunkel AR, et al. Infect Control Hosp Epidemiol. 1990 Sep;11(9):486-94. doi: 10.1086/646216. Infect Control Hosp Epidemiol. 1990. PMID: 2230052 Review.
Aztreonam, the first commercially available monobactam, has a wide range of activity against aerobic gram-negative bacilli. ...Aztreonam is a useful addition to the available antibiotics for treatment of gram-negative infections....
Aztreonam, the first commercially available monobactam, has a wide range of activity against aerobic gram-negative bacilli. ...Azt …
Aztreonam.
Cunha BA. Cunha BA. Urology. 1993 Mar;41(3):249-58. doi: 10.1016/0090-4295(93)90568-u. Urology. 1993. PMID: 8442309 Review.
Aztreonam is the first monobactam and is unique among beta-lactam antibiotics for its spectrum of activity that is exclusively active against gram-negative aerobic bacteria. Broad clinical experience with this agent supports its use in the treatment of adults with severe o …
Aztreonam is the first monobactam and is unique among beta-lactam antibiotics for its spectrum of activity that is exclusively active …
Aztreonam.
Childs SJ, Bodey GP. Childs SJ, et al. Pharmacotherapy. 1986 Jul-Aug;6(4):138-52. doi: 10.1002/j.1875-9114.1986.tb03468.x. Pharmacotherapy. 1986. PMID: 3534798 Review.
Accordingly, aztreonam remains active against many pathogens that are resistant to other beta-lactam antibiotics. ...Particularly in light of its safety and unique properties, aztreonam promises to be a useful alternative to aminoglycoside therapy....
Accordingly, aztreonam remains active against many pathogens that are resistant to other beta-lactam antibiotics. ...Particularly in …
Aztreonam-avibactam: The dynamic duo against multidrug-resistant gram-negative pathogens.
Al Musawa M, Bleick CR, Herbin SR, Caniff KE, Van Helden SR, Rybak MJ. Al Musawa M, et al. Pharmacotherapy. 2024 Dec;44(12):927-938. doi: 10.1002/phar.4629. Epub 2024 Nov 27. Pharmacotherapy. 2024. PMID: 39601336 Free PMC article. Review.
Antimicrobial resistance poses a significant public health challenge, particularly with the rise of gram-negative hospital-acquired infections resistant to carbapenems. Aztreonam-avibactam (ATM-AVI) is a promising new combination therapy designed to combat multidrug-resist …
Antimicrobial resistance poses a significant public health challenge, particularly with the rise of gram-negative hospital-acquired infectio …
[Role of aztreonam/avibactam in antibiotic therapy].
Kolář M. Kolář M. Klin Mikrobiol Infekc Lek. 2024 Sep;30(3):73-76. Klin Mikrobiol Infekc Lek. 2024. PMID: 40064017 Review. Czech.
The article reviews current options for the treatment of infections caused by carbapenemase-producing Enterobacterales, including the role of aztreonam/avibactam....
The article reviews current options for the treatment of infections caused by carbapenemase-producing Enterobacterales, including the role o …
Aztreonam: the first monobactam.
Neu HC. Neu HC. Med Clin North Am. 1988 May;72(3):555-66. doi: 10.1016/s0025-7125(16)30758-1. Med Clin North Am. 1988. PMID: 3280906 Free article. Review.
There are several areas in which the use of aztreonam seems logical. Infections caused by organisms sensitive to aztreonam that are known to be multiresistant to other agents can be treated directly with aztreonam in single, directed therapy, thus making the …
There are several areas in which the use of aztreonam seems logical. Infections caused by organisms sensitive to aztreonam tha …
Aztreonam.
Clark P. Clark P. Obstet Gynecol Clin North Am. 1992 Sep;19(3):519-28. Obstet Gynecol Clin North Am. 1992. PMID: 1436929 Review.
Aztreonam is a synthetic monobactam antibiotic that has excellent activity against aerobic gram-negative bacilli. ...
Aztreonam is a synthetic monobactam antibiotic that has excellent activity against aerobic gram-negative bacilli. ...
A review of the pharmacokinetics and pharmacodynamics of aztreonam.
Ramsey C, MacGowan AP. Ramsey C, et al. J Antimicrob Chemother. 2016 Oct;71(10):2704-12. doi: 10.1093/jac/dkw231. Epub 2016 Jun 21. J Antimicrob Chemother. 2016. PMID: 27334663 Review.
The monobactam aztreonam is currently being re-examined as a therapeutic agent in light of the global spread of carbapenem resistance in aerobic Gram-negative bacilli and aztreonam's stability to Ambler class B metallo-beta-lactamases. ...The monobactam ring is also …
The monobactam aztreonam is currently being re-examined as a therapeutic agent in light of the global spread of carbapenem resistance …
Aztreonam: a review of the first monobactam.
Westley-Horton E, Koestner JA. Westley-Horton E, et al. Am J Med Sci. 1991 Jul;302(1):46-9. doi: 10.1097/00000441-199107000-00011. Am J Med Sci. 1991. PMID: 2063887 Review.
Aztreonam represents the first synthetic monobactam marketed in the United States and is being viewed as a nontoxic alternative to the aminoglycosides. Advantages of aztreonam over the aminoglycosides include lack of ototoxicity and nephrotoxicity and better penetra …
Aztreonam represents the first synthetic monobactam marketed in the United States and is being viewed as a nontoxic alternative to th …
4,364 results